Alkermes plc, headquartered in Ireland, plans to present findings at SLEEP 2025 in Seattle.
1 report, 1 independent
Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alkermes plc, headquartered in Ireland, plans to present findings at SLEEP 2025 in Seattle.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- Insider MonkeyAlkermes plc (NASDAQ:ALKS) Launches Phase II Trial of ALKS 2680 for Idiopathic Hypersomnia We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Alkermes plc stands fourth on our list a